Featured News
Flexibility, creativity, and dedication to make better therapeutics are at the heart of what we do. Read more on recent updates and highlights around our contract drug manufacturing activities.
BIOVECTRA mRNA Vaccine and Bio-manufacturing Facility Announced
18 November 2021
Charlottetown, P.E.I. (November 18, 2021) – BIOVECTRA today announced plans for the development of a state-of-the-art facility specializing in the production and manufacturing of mRNA vaccines and therapeutics – one of the first of its kind in Canada. This exciting new capability will result from a joint private-public investment made by BIOVECTRA and the […]
31 March 2020
26 September 2018
5 March 2017
26 February 2017
29 January 2016
14 June 2014
25 June 2013
